FDA Webinar: Webinar Draft GFI on Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment; Availability - July 25, 2013
On July 25, 2013, FDA presented a webinar on a new draft guidance entitled "Draft Guidance for Industry on Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment; Availability."
The webinar provided an opportunity to learn about the guidance from individuals involved in its preparation. It was also intended to encourage the submission of questions or comments while the guidance is still in draft form.
Questions may be submitted to docket so that they can be formally processed by FDA.
Date FR NOA: 06/05/2013
Comment Period Closes: 08/09/2013
Jeffrey Murray, MD, MPH
Division of Antiviral Products
Office of Antimicrobial Products
Center for Drug Evaluation and Research (CDER)
WO, Bldg 22, Room 6370